Perceptive Advisors, LLC

Perceptive Advisors, LLC is a private investment firm specializing in healthcare and biotechnology investments. Founded in 1999, the firm manages approximately $8 billion across various strategies, including private equity, venture capital, hedge funds, and private credit. Perceptive Advisors is dedicated to identifying and directing financial resources toward the most promising technologies in modern healthcare, with a strong emphasis on scientific, technical, and investment expertise.

The firm's investment approach spans multiple stages, from seed and early-stage investments to growth, late-stage, pre-IPO, buyouts, turnarounds, and distressed situations. Geographically, Perceptive Advisors focuses on the United States, Africa, and Latin America, investing across a diverse range of industries such as biotechnology, healthcare, medical devices, pharmaceuticals, life sciences, healthcare IT, healthcare services, consumer products, medical devices & instruments, DeepTech & Hardware, fintech, and agriTech & foodTech.

Perceptive Advisors' portfolio includes companies like 4DMT, Achilles Therapeutics, AEGEA Medical, Agile Therapeutics, and Aquestive, among others. The firm's investment philosophy is driven by a commitment to supporting innovative healthcare breakthroughs and improving patient outcomes through strategic investments in transformative technologies within the life sciences sector.